• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ILLUMINOSS MEDICAL, INC PHOTODYNAMIC BONE STABILIZATION SYSTEM; IN VIVO INTRAMEDULLARY FIXATION ROD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ILLUMINOSS MEDICAL, INC PHOTODYNAMIC BONE STABILIZATION SYSTEM; IN VIVO INTRAMEDULLARY FIXATION ROD Back to Search Results
Catalog Number USSL-1700220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Post Operative Wound Infection (2446)
Event Date 05/31/2022
Event Type  Injury  
Event Description
An adverse event was entered into the illuminoss clinical study registry on march 26, 2024 for an event which started on may 31, 2022.A 75 year old female experienced a traumatic fall and left femur fracture which was treated with one 17x280mm illuminoss implant and a plate with 8 screws.About a month and half after the index procedure, the patient experienced an infection and a dehiscence wound on the left medial wound, likely with a draining sinus tunnel.
 
Manufacturer Narrative
Returned product evaluation was not possible in this case, as the device remains implanted.Dhr review: a review of manufacturing records for the device used in this complaint found that the device met specifications at the time of manufacture and release.Information from the doctor: the patient was treated with excisional wound debridement, irrigation, wound vacuum assisted closure, doxycycline, and cefazolin (antibiotics).Two months after the procedure the patient was treated with simple irrigation and debridement at bedside as the wound was not healing on (b)(6) 2022).Four months post-op the previous medial wound was found to be healing.A wound more distal than the previous was present with necrotic fat at the base and mild surrounding erythema with no purulence on (b)(6) 2022).At the 6 month post op follow up the user notes that the patient is immunocompromised, on remicade for crohn's, and has had some wound healing difficulty, which is not related to the device.Three days after the 6 month follow up, excisional debridement and irrigation was performed on the wound, and the previous dehiscence wound is now with visible purulence.It does appear there is a sinus track, mild erythematous, no abscesses or tenderness, and mild swelling.Per the user information from the registry, the cause of the patient would healing difficulty is due to her immunocompromised condition and is nothing directly related to the device.Medical oversight review: an internal medical oversight review was held in which the information and x-rays in this case were reviewed, and made the following conclusions: at the index procedure reduction looks good, and the device looks appropriately placed.The fracture has eventually healed and the device was intact.The surgery was done well, but was significant: there were several incisions, from the percutaneous screws, the lateral plate and in order to place the medial plate, the user has to make a large incision.The patient is immunocompromised and on remicade for crohn's, has a history of cancer, and this is a significant surgery for an immunocompromised patient.Medical oversight concurred with the report from the treating physician, that the cause of the wound infection was due to the patient being immunocompromised and undergoing a significant surgery, and was not device related.Review of ifu: a review of the device labeling and indications for use found that the device was used to treat an anatomy (femur) that is within its intended indications.Instructions for use 900365 was reviewed.The risk of infection, including wound complications, is included in the labeling.Conclusion: in the opinion of the treating physician and internal medical oversight, the wound infection is most likely due to the patient being immunocompromised and undergoing a significant surgical procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHOTODYNAMIC BONE STABILIZATION SYSTEM
Type of Device
IN VIVO INTRAMEDULLARY FIXATION ROD
Manufacturer (Section D)
ILLUMINOSS MEDICAL, INC
993 waterman ave
east providence RI 02914
Manufacturer (Section G)
ILLUMINOSS MEDICAL, INC
993 waterman ave
east providence RI 02914
Manufacturer Contact
robert rabiner
993 waterman ave
east providence, RI 02914
4017140008
MDR Report Key19176939
MDR Text Key341000381
Report Number3006845464-2024-00006
Device Sequence Number1
Product Code QAD
UDI-Device IdentifierM986USSL17002200
UDI-PublicM986USSL17002200
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181228
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2024
Device Catalogue NumberUSSL-1700220
Device Lot Number400897
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/26/2024
Initial Date FDA Received04/24/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient Weight84 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-